Glycoproteomics in neurodegenerative diseases
dc.contributor.author | Hwang, Hyejin | en_US |
dc.contributor.author | Zhang, Jianpeng | en_US |
dc.contributor.author | Chung, Kathryn A. | en_US |
dc.contributor.author | Leverenz, James B. | en_US |
dc.contributor.author | Zabetian, Cyrus P. | en_US |
dc.contributor.author | Peskind, Elaine R. | en_US |
dc.contributor.author | Jankovic, Joseph | en_US |
dc.contributor.author | Su, Zhen | en_US |
dc.contributor.author | Hancock, Aneeka M. | en_US |
dc.contributor.author | Pan, Catherine | en_US |
dc.contributor.author | Montine, Thomas J. | en_US |
dc.contributor.author | Pan, Sheng | en_US |
dc.contributor.author | Nutt, John | en_US |
dc.contributor.author | Albin, Roger L. | en_US |
dc.contributor.author | Gearing, Marla | en_US |
dc.contributor.author | Beyer, Richard P. | en_US |
dc.contributor.author | Shi, Min | en_US |
dc.contributor.author | Zhang, Jing | en_US |
dc.date.accessioned | 2010-01-05T15:08:45Z | |
dc.date.available | 2011-03-01T16:26:44Z | en_US |
dc.date.issued | 2010-01 | en_US |
dc.identifier.citation | Hwang, Hyejin; Zhang, Jianpeng; Chung, Kathryn A.; Leverenz, James B.; Zabetian, Cyrus P.; Peskind, Elaine R.; Jankovic, Joseph; Su, Zhen; Hancock, Aneeka M.; Pan, Catherine; Montine, Thomas J.; Pan, Sheng; Nutt, John; Albin, Roger; Gearing, Marla; Beyer, Richard P.; Shi, Min; Zhang, Jing (2010). "Glycoproteomics in neurodegenerative diseases." Mass Spectrometry Reviews 29(1): 79-125. <http://hdl.handle.net/2027.42/64521> | en_US |
dc.identifier.issn | 0277-7037 | en_US |
dc.identifier.issn | 1098-2787 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/64521 | |
dc.description.abstract | Protein glycosylation regulates protein function and cellular distribution. Additionally, aberrant protein glycosylations have been recognized to play major roles in human disorders, including neurodegenerative diseases. Glycoproteomics, a branch of proteomics that catalogs and quantifies glycoproteins, provides a powerful means to systematically profile the glycopeptides or glycoproteins of a complex mixture that are highly enriched in body fluids, and therefore, carry great potential to be diagnostic and/or prognostic markers. Application of this mass spectrometry-based technology to the study of neurodegenerative disorders (e.g., Alzheimer's disease and Parkinson's disease) is relatively new, and is expected to provide insight into the biochemical pathogenesis of neurodegeneration, as well as biomarker discovery. In this review, we have summarized the current understanding of glycoproteins in biology and neurodegenerative disease, and have discussed existing proteomic technologies that are utilized to characterize glycoproteins. Some of the ongoing studies, where glycoproteins isolated from cerebrospinal fluid and human brain are being characterized in Parkinson's disease at different stages versus controls, are presented, along with future applications of targeted validation of brain specific glycoproteins in body fluids. © 2009 Wiley Periodicals, Inc., Mass Spec Rev 29:79–125, 2010 | en_US |
dc.format.extent | 2156410 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Chemistry | en_US |
dc.subject.other | Analytical Chemistry and Spectroscopy | en_US |
dc.title | Glycoproteomics in neurodegenerative diseases | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Physics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Ann Arbor VAMC GRECC and Department of Neurology, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Washington, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Washington, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Neurology, Oregon Health and Science University, Portland, OR | en_US |
dc.contributor.affiliationother | Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA ; Department of Neurology, University of Washington School of Medicine, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Neurology, University of Washington School of Medicine, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA ; Department of Neurology, University of Washington School of Medicine, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Neurology, Baylor College of Medicine, Houston, TX | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Washington, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Washington, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Washington, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Washington, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Washington, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Neurology, Oregon Health and Science University, Portland, OR | en_US |
dc.contributor.affiliationother | Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA | en_US |
dc.contributor.affiliationother | Department of Environmental & Occupational Health Sciences, University of Washington School of Medicine, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Washington, Seattle, WA | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Washington, Seattle, WA ; Department of Pathology, University of Washington School of Medicine, HMC Box 359635, Seattle, WA 98104. | en_US |
dc.identifier.pmid | 19358229 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/64521/1/20221_ftp.pdf | |
dc.identifier.doi | 10.1002/mas.20221 | en_US |
dc.identifier.source | Mass Spectrometry Reviews | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.